Cochrane Corner: Antihypertensive efficacy of beta-1 selective beta blockers for primary hypertension

Area of Science:

• Cardiology
• Pharmacology
• Evidence-Based Medicine

Background:

• Beta blockers are a cornerstone in hypertension management.
• Primary hypertension necessitates effective and safe pharmacological interventions.

Purpose of the Study:

• To systematically review the efficacy and safety of beta-1 selective beta blockers for primary hypertension.
• To assess effects on blood pressure (BP), pulse pressure (PP), heart rate (HR), and adverse event withdrawals.

Main Methods:

• A Cochrane systematic review of 56 randomized placebo-controlled trials.
• Inclusion of 7812 patients with primary hypertension.

Main Results:

• Beta-1 selective beta blockers reduced systolic BP by 10 mmHg and diastolic BP by 8 mmHg.
• A reduction of 2 mmHg in pulse pressure and 11 bpm in heart rate was observed.
• No significant difference in withdrawal rates due to adverse effects compared to placebo.

Conclusions:

• Beta-1 selective beta blockers are effective antihypertensives with a favorable safety profile regarding adverse event withdrawals.
• Variability in efficacy among different beta-1 selective agents warrants consideration of methodological trial differences.
• Optimal antihypertensive drug selection requires balancing efficacy, tolerability, cardiovascular event prevention, and metabolic effects.